Eladocagene Exuparvovec-Tneq | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

56 results for “Eladocagene Exuparvovec-Tneq”

Trials

Active, not recruiting

A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants

13 participants · First posted May 26, 2021

Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening

3 participants · First posted Jul 29, 2022

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

51 participants · First posted Mar 4, 2019

Drugs

Eladocagene exuparvovec(Upstaza)

Conditions: Aromatic L-amino Acid Decarboxylase (AADC) Deficiency

Investigational

Fidanacogene elaparvovec(Durveqtix, Beqvez (previously Durveqtix))

Investigational

Patidistrogene bexoparvovec

News

View all 44 →

FDA Approves Eladocagene Exuparvovec-Tneq (Kebilidi) for AADC Deficiency

FDA Approves Kebilidi Gene Therapy for AADC Deficiency

FDA Approves Kebilidi (eladocagene exuparvovec) Gene Therapy for AADC Deficiency

Page 1 of 6